RxDoctor Payments Data

Adrien Eshraghi, MD

Otolaryngology · Miami, FLNPI 1740213958

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (50.9%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. Med-el Corporation accounts for 97.3% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2019 at $16,017 and has fallen 55.4% since, to $7,151 in 2025. Among otolaryngology clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$41,256in general payments, 2019–2025

Across 63 payments — averaging $654.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Med-el Corporation$40K
  • Cochlear Americas$677
  • Acclarent, Inc$113
  • Grace Medical, Inc.$110
  • Iotamotion, Inc.$83
  • Advanced Bionics, LLC$58
  • plus $89 from 2 others
$2,086,360in research payments, 2019–2025

Across 5 payments — averaging $417,272 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Med-el Corporation$2.1M

What the payments were for

  • Consulting fees$14,75036%
  • Travel & lodging$21,00251%
  • Food & beverage$4,02310%
  • Education$1,0653%
  • Charitable contribution$4171%

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$41,256 in reported general payments places this provider in the 95th percentile of 586 otolaryngology providers in Florida.

See all otolaryngology providers in Florida

Medicare billing

Part B allowed, 2024
$55,423
Medicare patients
216
Services billed
499

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth23$2,575
Ofloxacin29$727
Meclizine Hcl20$337
Ibuprofen11$74

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Miami

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →